SE0303491D0 - New use VI - Google Patents

New use VI

Info

Publication number
SE0303491D0
SE0303491D0 SE0303491A SE0303491A SE0303491D0 SE 0303491 D0 SE0303491 D0 SE 0303491D0 SE 0303491 A SE0303491 A SE 0303491A SE 0303491 A SE0303491 A SE 0303491A SE 0303491 D0 SE0303491 D0 SE 0303491D0
Authority
SE
Sweden
Prior art keywords
new use
compound
formula
treatment
regurgitation
Prior art date
Application number
SE0303491A
Other languages
Swedish (sv)
Inventor
Anders Lehmann
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0303491A priority Critical patent/SE0303491D0/en
Publication of SE0303491D0 publication Critical patent/SE0303491D0/en
Priority to PCT/SE2004/001876 priority patent/WO2005058326A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Abstract

The present invention relates to the use of a compound of formula (I) for the inhibition of transient lower esophageal sphincter relaxations. A further aspect of the invention is directed to the use of a compound of formula I for the treatment of gastro-esophageal reflux disease, as well as for the treatment of regurgitation.
SE0303491A 2003-12-19 2003-12-19 New use VI SE0303491D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0303491A SE0303491D0 (en) 2003-12-19 2003-12-19 New use VI
PCT/SE2004/001876 WO2005058326A1 (en) 2003-12-19 2004-12-15 USE OF QUINAZOLINONE DERIVATIVES FOR THE INHIBITION OF TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS (TLESRs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303491A SE0303491D0 (en) 2003-12-19 2003-12-19 New use VI

Publications (1)

Publication Number Publication Date
SE0303491D0 true SE0303491D0 (en) 2003-12-19

Family

ID=30768810

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303491A SE0303491D0 (en) 2003-12-19 2003-12-19 New use VI

Country Status (2)

Country Link
SE (1) SE0303491D0 (en)
WO (1) WO2005058326A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306839A (en) 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
GB0413618D0 (en) * 2004-06-17 2004-07-21 Novartis Ag Organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827988D0 (en) * 1988-11-30 1989-01-05 Smith Kline French Lab Chemical compounds
KR100883184B1 (en) * 2000-12-11 2009-02-12 암젠 인코포레이션 CXCR3 antagonists
TW200306839A (en) * 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
AU2003291761A1 (en) * 2002-11-04 2004-06-07 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics

Also Published As

Publication number Publication date
WO2005058326A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
WO2005077373A3 (en) Treatment of gastro-esophageal reflux disease (gerd)
WO2005077368A3 (en) Treatment of gastro-esophageal reflux disease (gerd)
IS7654A (en) Use of MGLUR5 antagonists for the treatment of gastro-oesophageal reflux disease
CY1113362T1 (en) DIARYL-ETHERS, AS A COMPETENT OPTIONAL COMPETITOR
EA200601358A1 (en) NEW CHEMAZ INHIBITORS
EA200870117A1 (en) AZAINDOL INHIBITORS AURORA-KINAZ
EA200601295A1 (en) 1,3-DIOXANE DERIVATIVES AND THEIR ANALOGUES APPLICABLE FOR THE TREATMENT I.A. OBESITY AND DIABETES
DE60335359D1 (en) phthalazinone
EA201000050A1 (en) SUBSTITUTED BICYCLOPLASTIC COMPOUNDS
DE602006016313D1 (en) BIPHENYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS C
ATE449099T1 (en) DERIVATIVES OF 2-TRIFLUORMETHYL-6-AMINOPURINE AS PHOSPHODIESTERASE 4 INHIBITORS
TW200635585A (en) Monocyclic substituted methanones
EA200700441A1 (en) NEW HETEROCYCLIC INHIBITORS NF-κB
EA200700997A1 (en) 2,5- and 2,6-DESIGNATED BENZAZOL ANALOGUES, USEFUL AS A PROTEINKINAZ INHIBITOR
EA200801596A1 (en) NEW 11-BETA-HYDROXYANDROST-4-EN-3-ONE
EA200701779A1 (en) DERIVATIVES (1,5-DIPHENYL-1N-PYRAZOL-3-IL) OXADIAZOLE, THEIR RECEIVING AND THEIR USE IN THERAPY
DE602005008471D1 (en) ARYLOXYETHYLAMINE DERIVATIVES WITH A COMBINATION AUSONIN RECOVERY INHIBITION
ATE417849T1 (en) PYRAZOLOA4,3-DÜPYRIMIDINE
SE0401653D0 (en) New compounds
EA200600330A1 (en) SUBSTITUTED IMIDAZOPIRIMIDINES FOR PREVENTION AND TREATMENT OF CANCER
EA200801123A1 (en) Derivatives of 6-heteroarylpyridinoyl, the method of their production and use of them in therapy
SE0303491D0 (en) New use VI
DK1562604T3 (en) Prostaglandin compounds for the treatment of obesity
SE0303490D0 (en) New use V
EA200601106A1 (en) TRICYCLIC IMIDAZOPIRIDINES FOR THE APPLICATION AS AN INHIBITOR OF GASTROLY SECRETION